Literature DB >> 12227617

Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study.

Birgit F Steffensen1, Søren Lyager, Birgit Werge, Jes Rahbek, Eva Mattsson.   

Abstract

The purpose of this study was to describe functional ability, muscle strength, forced vital capacity, and clinical events in participants with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) in the non-ambulatory stages of the diseases. Nineteen non-ambulatory participants with DMD (all males; 13 to 24 years) and 13 with SMA (six males, seven females; 11 to 57 years) were assessed once a year over 5 years. The assessments comprised functional ability measured with the EK scale and upper extremity grade, muscle strength measured with the manual muscle test, and forced vital capacity defined as a percentage of normal values (FVC%). In the DMD group all variables measured deteriorated and there was a direct correlation between them. In the SMA group only muscle strength and FVC% deteriorated and there was no close relation between the variables measured. In the DMD group, 16 participants had cardiorespiratory clinical events leading to death in five cases. In the SMA group only four participants had respiratory clinical events, none leading to death. Although the participants with SMA had been extremely weak and non-ambulatory since early childhood they were older and less exposed to life-threatening events than the participants with DMD.

Entities:  

Mesh:

Year:  2002        PMID: 12227617     DOI: 10.1017/s0012162201002663

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  9 in total

1.  Rasch analysis of clinical outcome measures in spinal muscular atrophy.

Authors:  Stefan J Cano; Anna Mayhew; Allan M Glanzman; Kristin J Krosschell; Kathryn J Swoboda; Marion Main; Birgit F Steffensen; Carole Bérard; Françoise Girardot; Christine A M Payan; Eugenio Mercuri; Elena Mazzone; Bakri Elsheikh; Julaine Florence; Linda S Hynan; Susan T Iannaccone; Leslie L Nelson; Shree Pandya; Michael Rose; Charles Scott; Reza Sadjadi; Mackensie A Yore; Cynthia Joyce; John T Kissel
Journal:  Muscle Nerve       Date:  2013-07-26       Impact factor: 3.217

2.  Inter-rater reliability of manual muscle strength testing in ICU survivors and simulated patients.

Authors:  Eddy Fan; Nancy D Ciesla; Alex D Truong; Vinodh Bhoopathi; Scott L Zeger; Dale M Needham
Journal:  Intensive Care Med       Date:  2010-03-06       Impact factor: 17.440

3.  Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings.

Authors:  Kate Bushby; Edward Connor
Journal:  Clin Investig (Lond)       Date:  2011-09

4.  Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module.

Authors:  Beatrice Berti; Lavinia Fanelli; Roberto de Sanctis; Roberta Onesimo; Concetta Palermo; Daniela Leone; Sara Carnicella; Giulia Norcia; Nicola Forcina; Giorgia Coratti; Valentina Giorgio; Antonella Cerchiari; Simona Lucibello; Richard Finkel; Marika Pane; Eugenio Mercuri
Journal:  J Neuromuscul Dis       Date:  2021

5.  Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.

Authors:  Andreea Mihaela Seferian; Amélie Moraux; Aurélie Canal; Valérie Decostre; Oumar Diebate; Anne Gaëlle Le Moing; Teresa Gidaro; Nicolas Deconinck; Frauke Van Parys; Wendy Vereecke; Sylvia Wittevrongel; Mélanie Annoussamy; Michèle Mayer; Kim Maincent; Jean-Marie Cuisset; Vincent Tiffreau; Severine Denis; Virginie Jousten; Susana Quijano-Roy; Thomas Voit; Jean-Yves Hogrel; Laurent Servais
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  Natural history of lung function in spinal muscular atrophy.

Authors:  Camiel A Wijngaarde; Esther S Veldhoen; Ruben P A van Eijk; Marloes Stam; Louise A M Otto; Fay-Lynn Asselman; Roelie M Wösten-van Asperen; Erik H J Hulzebos; Laura P Verweij-van den Oudenrijn; Bart Bartels; Inge Cuppen; Renske I Wadman; Leonard H van den Berg; Cornelis K van der Ent; W Ludo van der Pol
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

7.  Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.

Authors:  Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2020-03-12       Impact factor: 4.123

Review 8.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

Review 9.  [Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy].

Authors:  Guenther Bernert; Andreas Hahn; Cornelia Köhler; Sascha Meyer; Ulrike Schara; Kurt Schlachter; Regina Trollmann; Maggie C Walter
Journal:  Nervenarzt       Date:  2020-11-19       Impact factor: 1.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.